Today: 19 June 2026
Browse Category

Earnings Reports 9 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
AppLovin Corporation stock jumps as Wells Fargo lifts target ahead of Feb. 11 earnings

AppLovin Corporation stock jumps as Wells Fargo lifts target ahead of Feb. 11 earnings

AppLovin shares jumped 4.4% to $643.44 midday Friday after Wells Fargo raised its price target to $735 and reiterated an Overweight rating. The move outpaced gains in the Nasdaq and broader tech sector. AppLovin will report fourth-quarter and full-year results on Feb. 11 after market close. Investors are watching ad demand trends and upcoming Fed policy signals.
Lockheed Martin stock jumps as Trump order targets defense buybacks and dividends; earnings next

Lockheed Martin stock jumps as Trump order targets defense buybacks and dividends; earnings next

Lockheed Martin shares rose 4.2% to $539.96 Friday after President Trump signed an executive order tying dividends, buybacks, and executive pay to weapons delivery schedules. Defense stocks gained as Trump called for a $1.5 trillion 2027 military budget, far above the $901 billion set for 2026. Lockheed paid $2.3 billion each in dividends and buybacks last year. The company reports quarterly results Jan. 29.
Exxon Mobil (XOM) stock ticks up as filing flags up to $1.2 bln Q4 upstream hit

Exxon Mobil (XOM) stock ticks up as filing flags up to $1.2 bln Q4 upstream hit

Exxon Mobil shares rose 0.6% to $123.63 after warning lower crude prices may cut Q4 upstream earnings by $800 million to $1.2 billion, partly offset by stronger refining margins. Chevron gained 1.4% as oil prices climbed on supply concerns. Exxon also signed a memorandum with Turkey’s TPAO for exploration in the Black Sea and Mediterranean. Investors await Exxon’s Q4 results on Jan. 30.
JPMorgan stock today: Apple Card deal puts JPM in the spotlight as earnings near

JPMorgan stock today: Apple Card deal puts JPM in the spotlight as earnings near

JPMorgan Chase shares rose 0.4% to $331.12 after agreeing to take over Apple Card issuance from Goldman Sachs, a transition expected to move over $20 billion in balances and take about two years pending regulatory approval. JPMorgan will book a $2.2 billion credit-loss provision in Q4. Financial sector ETFs were little changed. Investors await JPMorgan’s Jan. 13 earnings for signals on credit costs and expenses.
Astronics (ATRO) stock rises again after Q4 revenue update and 2026 sales forecast

Astronics (ATRO) stock rises again after Q4 revenue update and 2026 sales forecast

Astronics shares rose 1.7% to $65.88 Friday morning after the company reported unaudited fourth-quarter revenue of $236–$239 million, up 14% year-over-year. Bookings reached $257 million for the quarter, with 2025 orders at $924 million. Management projected 2026 revenue between $950 million and $990 million. The stock surpassed analysts’ average 12-month target price of $60.75.
Barrick Mining stock price ticks up as gold steadies; U.S. jobs data and Feb. 5 results loom

Barrick Mining stock price ticks up as gold steadies; U.S. jobs data and Feb. 5 results loom

Barrick Mining shares rose 0.7% to $47.78 by 10:06 a.m. EST Friday as gold prices hovered near record highs. U.S. nonfarm payrolls increased by 50,000 in December, below forecasts, keeping attention on rates and the dollar. Barrick will report full-year and Q4 results on Feb. 5. Gold-backed ETFs saw $89 billion in inflows in 2025, lifting holdings to a record 4,025 tonnes.
Neogen stock steadies near $10 after 32% surge on raised outlook; next catalyst is Jan. 14

Neogen stock steadies near $10 after 32% surge on raised outlook; next catalyst is Jan. 14

Neogen shares traded near $9.74 premarket Friday after surging 32% Thursday on raised fiscal 2026 revenue guidance to $845–$855 million. Quarterly revenue fell 2.8% to $224.7 million, topping estimates, while net loss reached $15.9 million. Gross margin dropped to 47.5%. CEO Mike Nassif said integration of Petrifilm and manufacturing changes are underway.
Apple stock today: AAPL slips as Apple Card shifts to JPMorgan with earnings in view

Apple stock today: AAPL slips as Apple Card shifts to JPMorgan with earnings in view

Apple shares fell 0.5% to $259.04 early Friday after Apple and JPMorgan Chase announced Chase will take over as Apple Card issuer in a transition expected to last about 24 months. JPMorgan expects a $2.2 billion provision for credit losses tied to the deal. Investors await Apple’s Jan. 29 results for signals on holiday demand and services growth.
BigBear.ai stock ticks up in premarket — here’s what’s driving BBAI and the two January dates ahead

BigBear.ai stock ticks up in premarket — here’s what’s driving BBAI and the two January dates ahead

BigBear.ai shares rose 3% to $6.17 in Friday premarket trading after a broker downgrade earlier in the week. Investors are watching a Jan. 16 note redemption and a Jan. 22 shareholder vote to double authorized shares. A law firm issued an investor alert Thursday, adding to legal uncertainty. The stock remains volatile, trading near key technical levels.
1 157 158 159 160 161 257

Stock Market Today

  • Green360 Technologies Unveils MKX Ultra Fine, Expands High-Strength Concrete Market Reach
    June 18, 2026, 8:54 PM EDT. Green360 Technologies (ASX:GT3) launched MKX Ultra Fine, a second metakaolin product that replaces silica fume one-for-one in high-strength concrete, confirmed independently by University of Melbourne to match strength specs. This expands Green360's commercial platform beyond its existing MKX Calcined Clay product targeting fly ash and slag replacement. Silica fume commands a premium price in niche markets for infrastructure-grade concrete, potentially improving Green360's margins and market value. The product addresses critical supply shortages caused by declines in fly ash, slag, and silica fume availability due to coal plant closures and reduced silicon metal production. The company now offers a versatile toolkit responding to a shrinking supplementary cementitious materials (SCM) supply, providing concrete producers essential alternatives for durable infrastructure.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop